Contact: Dr. Ram Arudchandran
Contact Email: firstname.lastname@example.org
The HEAL Biomarker Program is dedicated to advancing biomarkers for pain conditions. The program is focused on supporting research to promote biomarkers that will improve the quality and efficiency of Phase II clinical trials and clinical practice. The HEAL Biomarker Program provides support for biomarker and endpoint discovery, along with analytical and clinical validation in a manner that is consistent with FDA guidelines.
An interactive Q&A webinar will be held for interested applicants on Wednesday, November 1, 2023, at 3:30 PM ET. All investigators interested in learning about the HEAL Biomarker funding opportunities are encouraged to participate. Investigators can find information about the current open funding opportunity at:
RFA-NS-24-023: HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 - Clinical Trial Optional)
Receipt date for this HEAL Biomarker Funding Opportunity is January 30, 2024